Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma

Patients with pancreatic adenocarcinoma have an increased propensity for diabetes. Recent studies suggest patients with diabetes and pancreatic adenocarcinoma treated with metformin have increased survival. This study was undertaken to determine whether metformin use is associated with increased sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Toomey, Paul, Teta, Anthony, Patel, Krishen, Downs, Darrell, Luberice, Kenneth, Ross, Sharona, S. Rosemurgy, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2017
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673127/
https://www.ncbi.nlm.nih.gov/pubmed/29177213
http://dx.doi.org/10.1097/IJ9.0000000000000015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673127/
https://www.ncbi.nlm.nih.gov/pubmed/29177213
http://dx.doi.org/10.1097/IJ9.0000000000000015

Ejemplares similares